Finance

Lists
R1MD34:BVMF
Resmed Inc Bdr
294,47 R$
0,00%
(0,00) 1D
13 ოქტ, 11:58:14 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for R1MD34...
Mkt. cap
33,09 მლრდ.
Avg. vol.
1,00
Volume
0,00
52-wk high
354,88 R$
52-wk low
238,41 R$
Shares outstanding
140,64 მლნ.
No. of employees
11 ათ.
Mkt. cap
33,09 მლრდ.
Avg. vol.
1,00
Volume
0,00
52-wk high
354,88 R$
52-wk low
238,41 R$
Shares outstanding
140,64 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
TipRanks
TipRanks
·
1 დღის წინ
ResMed Stock Stumbles As Structural Fears Mount
Benzinga
Benzinga
·
2 დღის წინ
ResMed Q4 2026 Earnings Call Transcript
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc Bdr
CEOმაიკლ ჯეი ფარელ
Employees11,4 ათ.
Foundedივნ 1989
Headquartersსან-დიეგო, კალიფორნია, ამერიკის შეერთებული შტატები
SectorMedical device
Websiteresmed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,34 მლრდ.
1,42 მლრდ.
1,43 მლრდ.
1,46 მლრდ.
Cost of goods sold
506,94 მლნ.
536,28 მლნ.
532,58 მლნ.
594,13 მლნ.
Cost of revenue
506,94 მლნ.
536,28 მლნ.
532,58 მლნ.
594,13 მლნ.
Research and development expenses
87,32 მლნ.
90,97 მლნ.
94,27 მლნ.
105,72 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,19 მლნ.
275,70 მლნ.
279,80 მლნ.
293,36 მლნ.
Operating expense
366,29 მლნ.
386,24 მლნ.
393,16 მლნ.
417,88 მლნ.
Total operating expenses
873,24 მლნ.
922,51 მლნ.
925,74 მლნ.
1,01 მლრდ.
Operating income
462,35 მლნ.
500,30 მლნ.
505,67 მლნ.
451,64 მლნ.
Other non operating income
-3,84 მლნ.
42,00 ათ.
181,00 ათ.
4,40 მლნ.
EBT including unusual items
446,79 მლნ.
496,15 მლნ.
502,31 მლნ.
474,16 მლნ.
EBT excluding unusual items
468,79 მლნ.
504,48 მლნ.
518,30 მლნ.
476,09 მლნ.
Income tax expense
98,26 მლნ.
103,56 მლნ.
103,58 მლნ.
90,73 მლნ.
Effective tax rate
21,99%
20,87%
20,62%
19,14%
Other operating expenses
-
-
-
-
Net income
348,54 მლნ.
392,59 მლნ.
398,73 მლნ.
383,43 მლნ.
Net profit margin
26,10%
27,59%
27,86%
26,20%
Earnings per share
2,55
2,81
0,29
0,30
Interest and investment income
4,69 მლნ.
4,46 მლნ.
3,80 მლნ.
31,76 მლნ.
Interest expense
-
-
-
-
Net interest expenses
4,69 მლნ.
4,46 მლნ.
3,80 მლნ.
31,76 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
503,64 მლნ.
543,79 მლნ.
558,22 მლნ.
490,13 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები